Preeminent IP position gives Sherlock freedom to operate and commercialize across multiple CRISPR business avenues WATERTOWN, Mass., Feb. 21, 2023 /PRNewswire/ -- Sherlock Biosciences, a company ...

CRISPR technology has revolutionized genetic testing and disease detection, offering precise, rapid, and cost-effective diagnostic solutions. This gene-editing tool has been adapted for molecular ...

Thanks to a novel tool that detects bacteria in saliva using SHERLOCK, the evolution of CRISPR, you may soon be able to leave the dentist after a checkup with more comprehensive information about the ...

Sherlock Biosciences has bought global molecular diagnostics company Sense Biodetection based out of Cambridge, U.K., to help it reach its goal of making diagnostics easy to use, cheap, disposable, ...

Sherlock Biosciences has gained U.S. rights to a patent for diagnostic use of a CRISPR system based on the smaller Cas12 enzyme as single RNA-guided endonuclease. Sherlock—whose co-founders include ...